FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892313110> ?p ?o ?g. }

• W2892313110 endingPage "589" @default.
• W2892313110 startingPage "584" @default.
• W2892313110 abstract "Bmi1, a polycomb group gene, is essential for self-renewal of stem cells and is frequently upregulated in various cancer cells. We aimed to investigate the effect of Bmi1 silencing on cancer stemness and chemosensitivity in endometrial cancer using targeted siRNA approach in HEC1A and Ishikawa cells. Cell viability after treatment with Bmi1 siRNA was assessed using the MTT assay, and cell apoptosis was visualized using the TdT-mediated dUTP nick-end labeling (TUNEL) method. Western blotting, migration assays and invasion assays were performed to detect changes in the stem-like properties of cancer cells. To evaluate the anticancer effect of Bmi1 silencing, HEC1A and Ishikawa cells were treated with 100 nM Bmi1 siRNA and/or 40 μM cisplatin. In the MTT assay, compared to control, viability of HEC1A and Ishikawa cells significantly decreased after Bmi1 siRNA treatment in a dose-dependent manner. Bmi1 silencing using siRNA increased the expression of cleaved caspase-3 and cleaved poly adenosine diphosphate-ribose polymerase polymerase (PARP) as observed in the western blot analysis. Apoptosis significantly increased in the HEC1A and Ishikawa cells treated with 100 nM Bmi1 siRNA for 48 h than in the control cells in TUNEL assay. SOX2 and Oct4 expression decreased in the HEC1A and Ishikawa cells treated with Bmi1 siRNA, while E-cadherin expression increased. Further, migratory and invasive properties were significantly inhibited by Bmi1 siRNA treatment in both cell lines. Notably, viability of HEC1A and Ishikawa cells decreased more when they were concurrently treated with Bmi1 siRNA and cisplatin compared to when they were treated with Bmi1 siRNA or cisplatin alone. Bmi1 silencing suppresses cancer stemness in HEC1A and Ishikawa cells. Concurrent treatment with Bmi1 siRNA and cisplatin resulted in additive anticancer effect with a cell line-specific pattern, which was higher than that shown by cisplatin treatment alone." @default.
• W2892313110 created "2018-09-27" @default.
• W2892313110 creator A5016800949 @default.
• W2892313110 creator A5022124273 @default.
• W2892313110 creator A5033381521 @default.
• W2892313110 creator A5047672495 @default.
• W2892313110 creator A5051628291 @default.
• W2892313110 creator A5053233818 @default.
• W2892313110 creator A5059193002 @default.
• W2892313110 date "2018-12-01" @default.
• W2892313110 modified "2023-10-16" @default.
• W2892313110 title "Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells" @default.
• W2892313110 cites W1419112127 @default.
• W2892313110 cites W1964081206 @default.
• W2892313110 cites W1977895957 @default.
• W2892313110 cites W1979556742 @default.
• W2892313110 cites W2007781337 @default.
• W2892313110 cites W2031951376 @default.
• W2892313110 cites W2044853511 @default.
• W2892313110 cites W2049400611 @default.
• W2892313110 cites W2092015913 @default.
• W2892313110 cites W2166666333 @default.
• W2892313110 cites W2170086508 @default.
• W2892313110 cites W2218527356 @default.
• W2892313110 cites W2365209119 @default.
• W2892313110 cites W2434797444 @default.
• W2892313110 cites W2469232719 @default.
• W2892313110 cites W2570618306 @default.
• W2892313110 cites W2785389296 @default.
• W2892313110 doi "https://doi.org/10.1016/j.biopha.2018.09.041" @default.
• W2892313110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30243092" @default.
• W2892313110 hasPublicationYear "2018" @default.
• W2892313110 type Work @default.
• W2892313110 sameAs 2892313110 @default.
• W2892313110 citedByCount "20" @default.
• W2892313110 countsByYear W28923131102019 @default.
• W2892313110 countsByYear W28923131102020 @default.
• W2892313110 countsByYear W28923131102021 @default.
• W2892313110 countsByYear W28923131102022 @default.
• W2892313110 countsByYear W28923131102023 @default.
• W2892313110 crossrefType "journal-article" @default.
• W2892313110 hasAuthorship W2892313110A5016800949 @default.
• W2892313110 hasAuthorship W2892313110A5022124273 @default.
• W2892313110 hasAuthorship W2892313110A5033381521 @default.
• W2892313110 hasAuthorship W2892313110A5047672495 @default.
• W2892313110 hasAuthorship W2892313110A5051628291 @default.
• W2892313110 hasAuthorship W2892313110A5053233818 @default.
• W2892313110 hasAuthorship W2892313110A5059193002 @default.
• W2892313110 hasBestOaLocation W28923131101 @default.
• W2892313110 hasConcept C104317684 @default.
• W2892313110 hasConcept C119056186 @default.
• W2892313110 hasConcept C121608353 @default.
• W2892313110 hasConcept C153911025 @default.
• W2892313110 hasConcept C185592680 @default.
• W2892313110 hasConcept C190283241 @default.
• W2892313110 hasConcept C196795494 @default.
• W2892313110 hasConcept C22615655 @default.
• W2892313110 hasConcept C2776694085 @default.
• W2892313110 hasConcept C2778239845 @default.
• W2892313110 hasConcept C2778987575 @default.
• W2892313110 hasConcept C2780783641 @default.
• W2892313110 hasConcept C28328180 @default.
• W2892313110 hasConcept C502942594 @default.
• W2892313110 hasConcept C53227056 @default.
• W2892313110 hasConcept C54009773 @default.
• W2892313110 hasConcept C54355233 @default.
• W2892313110 hasConcept C55427017 @default.
• W2892313110 hasConcept C55493867 @default.
• W2892313110 hasConcept C62112901 @default.
• W2892313110 hasConcept C81885089 @default.
• W2892313110 hasConcept C86803240 @default.
• W2892313110 hasConcept C95444343 @default.
• W2892313110 hasConcept C96232424 @default.
• W2892313110 hasConceptScore W2892313110C104317684 @default.
• W2892313110 hasConceptScore W2892313110C119056186 @default.
• W2892313110 hasConceptScore W2892313110C121608353 @default.
• W2892313110 hasConceptScore W2892313110C153911025 @default.
• W2892313110 hasConceptScore W2892313110C185592680 @default.
• W2892313110 hasConceptScore W2892313110C190283241 @default.
• W2892313110 hasConceptScore W2892313110C196795494 @default.
• W2892313110 hasConceptScore W2892313110C22615655 @default.
• W2892313110 hasConceptScore W2892313110C2776694085 @default.
• W2892313110 hasConceptScore W2892313110C2778239845 @default.
• W2892313110 hasConceptScore W2892313110C2778987575 @default.
• W2892313110 hasConceptScore W2892313110C2780783641 @default.
• W2892313110 hasConceptScore W2892313110C28328180 @default.
• W2892313110 hasConceptScore W2892313110C502942594 @default.
• W2892313110 hasConceptScore W2892313110C53227056 @default.
• W2892313110 hasConceptScore W2892313110C54009773 @default.
• W2892313110 hasConceptScore W2892313110C54355233 @default.
• W2892313110 hasConceptScore W2892313110C55427017 @default.
• W2892313110 hasConceptScore W2892313110C55493867 @default.
• W2892313110 hasConceptScore W2892313110C62112901 @default.
• W2892313110 hasConceptScore W2892313110C81885089 @default.
• W2892313110 hasConceptScore W2892313110C86803240 @default.
• W2892313110 hasConceptScore W2892313110C95444343 @default.
• W2892313110 hasConceptScore W2892313110C96232424 @default.
• W2892313110 hasFunder F4320322557 @default.

• next